Lv1
44 积分 2026-07-14 加入
The evolution of cyclosporine treatments for treatment of ocular surface diseases
12小时前
已完结
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
2天前
已完结
病理性近视继发脉络膜新生血管形成的机制与治疗
3天前
已完结
Comparison of the Effectiveness and Prognostic Factors of Intravitreal Ranibizumab between Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy over 24 Months of Follow-Up
4天前
已完结
Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy
7天前
已完结
Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment
7天前
已完结
Polypoidal choroidal vasculopathy
7天前
已完结
Early glucocorticoid withdrawal in severe ANCA-associated vasculitis treated with combination cyclophosphamide and rituximab: a single-centre case series
8天前
已完结
SUNet: A Lesion Regularized Model for Simultaneous Diabetic Retinopathy and Diabetic Macular Edema Grading
16天前
已关闭
The effect of denosumab and alendronate on trabecular plate and rod microstructure at the distal tibia and radius: A post-hoc HR-pQCT study
17天前
已完结
皖公网安备34019202002308
